Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

How different drugs affect BIS-EEG during anesthesia with propofol-remifentanil

Official title: The Effects of Midazolam, Dexmedetomidine, and Esketamine on Bispectral Index and Raw Electroencephalogram in Patients Under Propofol-Remifentanil Baseline Anesthesia

Run by China-Japan Friendship Hospital · NCT07699523 · Data updated 2026-11-12

This study tests how adding drugs like midazolam, dexmedetomidine, or esketamine changes BIS and raw EEG readings in adults having elective gallbladder surgery under standard anesthesia.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment120 (estimated)
SponsorChina-Japan Friendship Hospital
Academic / other
Locations2 sites (Beijing, Beijing Municipality and 1 other locations)
StatusRecruiting
StartedJuly 14, 2026
Main results expectedJune 30, 2027
Study endsDecember 30, 2027
Registry record updatedOctober 28, 2026
Trial IDNCT07699523 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with ASA I-II, BMI 18-28, scheduled for elective laparoscopic cholecystectomy expected to last ≥45 minutes, and planned for propofol-remifentanil anesthesia with BIS and raw EEG monitoring.

Probably not a fit

Patients with current neurological or psychiatric disorders, cognitive impairment, or certain cardiovascular conditions may not experience a benefit and may be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this single-center randomized trial, adults undergoing elective laparoscopic cholecystectomy with propofol-remifentanil anesthesia will be assigned to receive either midazolam, dexmedetomidine, esketamine, or no additional drug. Continuous BIS values and raw EEG signals will be recorded to see how each adjunct drug influences brain activity measurements beyond the expected depth of anesthesia. The goal is to determine whether BIS readings remain accurate when multiple anesthetic drugs are used. The study will help clarify whether BIS-EEG monitoring can reliably reflect anesthesia depth in this multi-drug context.

Why it matters

Potential benefit: If successful, the findings could improve interpretation of BIS-EEG monitoring when multiple anesthetics are used, potentially guiding safer anesthesia management.

How similar studies have gone: Previous studies suggest BIS can be affected by certain drugs, so this trial adds focused data on midazolam, dexmedetomidine, and esketamine in the same anesthesia context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ASA physical status I-II;
2. BMI 18-28 kg/m²;
3. Scheduled for elective laparoscopic cholecystectomy, with an expected surgical duration from skin incision to completion of wound closure of ≥45 min;
4. Planned to receive propofol-remifentanil total intravenous anesthesia, with routine intraoperative BIS monitoring and simultaneous acquisition of raw EEG signals;
5. Voluntarily agrees to participate in this study, has signed the informed consent form, and is able to cooperate with the intervention and assessment procedures.

Exclusion Criteria:

1. A confirmed history of psychiatric or neurological disorders, or use of antipsychotics, antidepressants, benzodiazepines, or other sedative-hypnotic drugs within 4 weeks before surgery;
2. Cognitive impairment identified by Mini-Cog screening;
3. Poorly controlled or untreated hypertension, sinus bradycardia, or severe cardiac conduction block;
4. Acute angle-closure glaucoma;
5. Known allergy to any required anesthetic drug;
6. Difficulty in electrode placement or any condition that may interfere with EEG monitoring.

Where it's running

  • China-Japan Friendship Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • China-Japan Friendship Hospital
    Beijing, Beijing Municipality, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.